from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1208/gpgS

LFCtreatmentdescriptionclass of inhibitor

-0.398

Amikacinug/mL Amikacintranslation

-1.743

Cap5-10ug/mL Capreomycintranslation

-1.210

Rox10-50 ug/mL Roxithromycintranslation

-0.208

SM2-5 ug/mL Streptomycintranslation

-0.794

Tet5-10 ug/mL Tetracyclinetranslation

1.599

Rif0.2-5ug/mL Rifampicintranscription

-0.548

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.430

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.867

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.269

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.053

Clofazimine10-13 ug/mL Clofaziminerespiration

0.279

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.689

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.530

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.001

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.402

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.874

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.032

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.233

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.554

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.980

KCN5-20 ug/mL Potassium cyaniderespiration

0.308

NaN30.2-2 mM Sodium aziderespiration

0.027

Nigericin50 uM Nigericinrespiration

0.112

TRC10-150 ug/mL Triclosanrespiration

-0.387

TRZ10-25 ug/mL Thioridazinerespiration

-2.396

Valinomycin0.5-10 uM Valinomycinrespiration

0.981

ZnSO42 mM ZnSO4respiration

-0.135

menadione6-10 ug/mL Menadionerespiration

0.298

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.174

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.072

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.086

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.723

NRP_1Non-replicating persistence stage 1dosRassociated

0.312

Amp0.2mg/mL AmpicillincellWall

0.475

Cephalexin20-100 ug/mL CephalexincellWall

0.320

Cerulenin0.32-5 ug/mL CerulenincellWall

0.326

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.867

EMB10-20 ug/mL EthambutolcellWall

0.783

Eta12-40 ug/mL EthionamidecellWall

1.056

INH0.2-0.4 ug/mL IsoniazidcellWall

0.410

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.183

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.049

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.020

BZA0.12 mg/mL BenzamidearomaticAmides

-0.108

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.421

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.216

H2O24 mM hydrogen peroxideDNAdamaging

-0.102

Levo10 ug/mL LevofloxacinDNAdamaging

-0.329

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.009

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.246

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.206

UVUV-irradiationDNAdamaging

0.737

ARP41-4 ug/mL Antitubercular compound ARP4?

0.030

Antimycin12.5-50 ug/mL Antimycin A?

0.354

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.008

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.129

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.709

PA8240.2-2 ug/mL PA-824?

-0.372

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.525

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.747

Verapamil50 uM Verapamil?

0.717

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.059

methoxatin10-20 ug/mL Methoxatin?